Assessment of mumps-containing vaccine effectiveness by dose during 2006 to 2020 in Quzhou, China

References

• Grennan D. Mumps. Jama. 2019;322:1. doi:10.1001/jama.2019.10982.
   Web of Science ®Google Scholar
• Moghe CS, Goel P, Singh J, Nayak NR, Dhuria M, Jain R, Yadav R, Saroha E, Sodha SV, Aggarwal CS, et al. Mumps outbreak investigation in Jaisalmer, Rajasthan, India, June-r̥september 2016. J Med Virol. 2019;91:347–6. doi:10.1002/jmv.25324.
   PubMed Web of Science ®Google Scholar
• Marx GE, Burakoff A, Barnes M, Hite D, Metz A, Miller K, Davizon ES, Chase J, McDonald C, McClean M, et al. Mumps outbreak in a Marshallese community — Denver metropolitan area, Colorado, 2016–2017. MMWR Morb Mortal Wkly Rep. 2018;67:1143–1146. doi:10.15585/mmwr.mm6741a2.
   PubMed Web of Science ®Google Scholar
• Lewnard JA, Grad YH. Vaccine waning and mumps re-emergence in the United States. Sci Transl Med. 2018;10. doi:10.1126/scitranslmed.aao5945.
   Web of Science ®Google Scholar
• Westphal DW, Eastwood A, Levy A, Davies J, Huppatz C, Gilles M, Lyttle H, Williams SA, Dowse GK. A protracted mumps outbreak in Western Australia despite high vaccine coverage: a population-based surveillance study. Lancet Infect Dis. 2019;19:177–184. doi:10.1016/S1473-3099(18)30498-5.
   PubMed Web of Science ®Google Scholar
• Lu Q, Ding Z, Wu C, Wu H, Lin J. Analysis of epidemiological characteristics of notifiable diseases reported in children aged 0–14 years from 2008 to 2017 in Zhejiang Province, China. Int J Environ Res Public Health. 2019;16:168. doi:10.3390/ijerph16020168.
   PubMed Web of Science ®Google Scholar
• Zhou C, Song W, Yin Z, Li S, Gong X, Fang Q, et al. Assessing the changes of mumps characteristics with different vaccination strategies using surveillance data: importance to introduce the 2-dose schedule in Quzhou of China. J Immunol Res. 2020;2020:8130760. doi:10.1155/2020/8130760.
   PubMed Web of Science ®Google Scholar
• Yin Z, Zheng C, Fang Q, Gong X, Cao G, Li J, Xiang Z, Song W. Introduction of two-dose mumps-containing vaccine into routine immunization schedule in quzhou, china, using cox-proportional hazard model. J Immunol Res. 2021;2021:5990417. doi:10.1155/2021/5990417.
   PubMed Web of Science ®Google Scholar
• Ramanathan R, Voigt EA, Kennedy RB, Poland GA. Knowledge gaps persist and hinder progress in eliminating mumps. Vaccine. 2018;36:3721–3726. doi:10.1016/j.vaccine.2018.05.067.
   PubMed Web of Science ®Google Scholar
• Gu XX, Plotkin SA, Edwards KM, Sette A, Mills KHG, Levy O, Sant AJ, Mo A, Alexander W, Lu KT, et al. Waning immunity and microbial vaccines—Workshop of the National Institute of allergy and infectious diseases. Clin Vaccine Immunol. 2017;24. doi:10.1128/CVI.00034-17
   Google Scholar
• Deeks SL, Lim GH, Simpson MA, Gagne L, Gubbay J, Kristjanson E, Fung C, Crowcroft NS. An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada. Cmaj. 2011;183:1014–1020. doi:10.1503/cmaj.101371.
   PubMed Web of Science ®Google Scholar
• Fields VS, Safi H, Waters C, Dillaha J, Capelle L, Riklon S, Wheeler JG, Haselow DT. Mumps in a highly vaccinated Marshallese community in Arkansas, USA: an outbreak report. Lancet Infect Dis. 2019;19:185–192. doi:10.1016/S1473-3099(18)30607-8.
   PubMed Web of Science ®Google Scholar
• Liu Y, Xiong Y, Liang Y, Deng X, Hu Y, Hu R, Chen Q, Tang F, Wang Z, Sun X, et al. Waning immunity and potential asymptomatic infection in 3–7 years old children who received one dose of measles-mumps-rubella vaccine: a 4-year prospective study. Vaccine. 2021;39:3509–3515. doi:10.1016/j.vaccine.2021.05.008.
   PubMed Web of Science ®Google Scholar
• Ma R, Lu L, Zhou T, Pan J, Chen M, Pang X. Mumps disease in Beijing in the era of two-dose vaccination policy, 2005-2016. Vaccine. 2018;36:2589–2595. doi:10.1016/j.vaccine.2018.03.074.
   PubMed Web of Science ®Google Scholar
• Saxena B, Ramachandran VG, Saha R, Shah D. Mumps antibody titer in MMR-vaccinated and vaccine naive children at a public hospital in Delhi. Indian Pediatr. 2021;58:137–139. doi:10.1007/s13312-021-2129-2.
   PubMed Web of Science ®Google Scholar
• Qin W, Wang Y, Yang T, Xu XK, Meng XM, Zhao CJ, Li S-Y, Xie S-Y, Li K-C, Su H, et al. Outbreak of mumps in a student population with high vaccination coverage in China: time for two-dose vaccination. Human Vacc Immunother. 2019;15:2106–2111. doi:10.1080/21645515.2019.1581526.
   PubMed Web of Science ®Google Scholar
• Schenk J, Abrams S, Theeten H, Van Damme P, Beutels P, Hens N. Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21:286–295. doi:10.1016/S1473-3099(20)30442-4.
   PubMed Web of Science ®Google Scholar
• Vygen S, Fischer A, Meurice L, Mounchetrou Njoya I, Gregoris M, Ndiaye B, Ghenassia A, Poujol I, Stahl JP, Antona D, et al. Waning immunity against mumps in vaccinated young adults, France 2013. Eurosurveillance. 2016;21:30156. doi:10.2807/1560-7917.ES.2016.21.10.30156.
   Web of Science ®Google Scholar
• Waugh CJ, Willocks LJ, Templeton K, Stevenson J. Recurrent outbreaks of mumps in Lothian and the impact of waning immunity. Epidemiol Infect. 2020;148:e131. doi:10.1017/S0950268820001296.
   PubMed Web of Science ®Google Scholar
• El Zarif T, Kassir MF, Bizri N, Kassir G, Musharrafieh U, Bizri AR. Measles and mumps outbreaks in Lebanon: trends and links. BMC Infect Dis. 2020;20:244. doi:10.1186/s12879-020-04956-1.
   PubMed Web of Science ®Google Scholar
• Pang H, Zhou Y, Zhao W, Jiang Q. Epidemiological changes in mumps infections between 1990 and 2017 in urban area of Shanghai, China. Human Vacc Immunother. 2021;17:1358–1365. doi:10.1080/21645515.2020.1827610.
   PubMed Web of Science ®Google Scholar
• Won H, Kim AR, Yoo JS, Chung GT, Kang HJ, Kim SJ, Kim SS, Lee J-W. Cross-Neutralization between vaccine and circulating wild-type mumps viruses in Korea. Vaccine. 2021;39:1870–1876. doi:10.1016/j.vaccine.2021.01.039.
   PubMed Web of Science ®Google Scholar
• Bankamp B, Hickman C, Icenogle JP, Rota PA. Successes and challenges for preventing measles, mumps and rubella by vaccination. Curr Opin Virol. 2019;34:110–116. doi:10.1016/j.coviro.2019.01.002.
   PubMed Web of Science ®Google Scholar
• Willocks LJ, Guerendiain D, Austin HI, Morrison KE, Cameron RL, Templeton KE, et al. An outbreak of mumps with genetic strain variation in a highly vaccinated student population in Scotland. Epidemiol Infect. 2017;145:3219–3225. doi:10.1017/S0950268817002102.
   PubMed Web of Science ®Google Scholar
• He HQ, Zhang B, Yan R, Li Q, Fu J, Tang XW, et al. Economic evaluation on different two-dose-vaccination-strategies related to measles, mumps and rubella combined attenuated live vaccine. Chin J Epidemiol. 2016;37:1121–1126.
   Google Scholar
• Wang D, Nie T, Pan F, Wang Y, Wang J, Qin W. Loss of protective immunity of two-dose mumps-containing vaccine over time: concerns with the new strategy of the mumps immunization program in China. Human Vacc Immunother. 2021;17:2072–2077. doi:10.1080/21645515.2020.1861877.
   PubMed Web of Science ®Google Scholar
• Patel LN, Arciuolo RJ, Fu J, Giancotti FR, Zucker JR, Rakeman JL, Rosen JB. Mumps Outbreak Among a Highly Vaccinated University Community-New York City, January-April 2014. Clin Infect Dis. 2017;64:408–412. doi:10.1093/cid/ciw762.
   PubMed Web of Science ®Google Scholar
• Trotz-Williams LA, Mercer NJ, Paphitis K, Walters JM, Wallace D, Kristjanson E, Gubbay J, Mazzulli T. Challenges in interpretation of diagnostic test results in a mumps outbreak in a highly vaccinated population. Clin Vaccine Immunol. 2017;24. doi:10.1128/CVI.00542-16.
   PubMedGoogle Scholar